ArticleVaccines2022

Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination.

Floriana Bonura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.